for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover The Lancet
  [SJR: 14.638]   [H-I: 600]   [2320 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 0140-6736 - ISSN (Online) 1474-547X
   Published by Elsevier Homepage  [3177 journals]
  • Contemporary cardiovascular risk prediction
    • Authors: Johanna A A G Damen; Lotty Hooft; Karel G M Moons
      Pages: 1867 - 1868
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Johanna A A G Damen, Lotty Hooft, Karel G M Moons


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30842-0
       
  • Taking aim at cholera
    • Authors: Eric Mintz
      Pages: 1868 - 1870
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Eric Mintz


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30543-9
       
  • Pathology and laboratory medicine: the Cinderella of health systems
    • Authors: Sabine Kleinert; Richard Horton
      Pages: 1872 - 1873
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Sabine Kleinert, Richard Horton


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30457-4
       
  • Laboratory medicine in low-income and middle-income countries: progress
           and challenges
    • Authors: John N Nkengasong; Katy Yao; Philip Onyebujoh
      Pages: 1873 - 1875
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): John N Nkengasong, Katy Yao, Philip Onyebujoh


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30308-8
       
  • Pathology and laboratory medicine in partnership with global surgery:
           working towards universal health coverage
    • Authors: Isabelle Citron; Kristin Sonderman; John G Meara
      Pages: 1875 - 1877
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Isabelle Citron, Kristin Sonderman, John G Meara


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30310-6
       
  • Emergency deployment of oral cholera vaccine for the Rohingya in
           Bangladesh
    • Authors: Firdausi Qadri; Abul Kalam Azad; Meerjady Sabrina Flora; Ashraful Islam Khan; Md Taufiqul Islam; G Balakrish Nair; Poonam Khetrapal Singh; John D Clemens
      Pages: 1877 - 1879
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Firdausi Qadri, Abul Kalam Azad, Meerjady Sabrina Flora, Ashraful Islam Khan, Md Taufiqul Islam, G Balakrish Nair, Poonam Khetrapal Singh, John D Clemens


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30993-0
       
  • Offline: John E Fogarty and the defeat of Donald J Trump
    • Authors: Richard Horton
      First page: 1882
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Richard Horton


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)31072-9
       
  • EMRO Regional Director to be elected to head office
    • Authors: John Zarocostas
      Pages: 1883 - 1884
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): John Zarocostas


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)31061-4
       
  • Cochrane postpones comprehensive free access to reviews
    • Authors: Talha Burki
      First page: 1885
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Talha Burki


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)31062-6
       
  • The pressures of medical practice
    • Authors: Margaret McCartney
      Pages: 1887 - 1888
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Margaret McCartney


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)31003-1
       
  • Kenneth Fleming: making the global case for pathology
    • Authors: Geoff Watts
      First page: 1889
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Geoff Watts


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30623-8
       
  • Robert Johns Haggerty
    • Authors: Geoff Watts
      First page: 1892
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Geoff Watts


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)31006-7
       
  • Time to eradicate HTLV-1: an open letter to WHO
    • Authors: Fabiola Martin; Yutaka Tagaya; Robert Gallo
      Pages: 1893 - 1894
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Fabiola Martin, Yutaka Tagaya, Robert Gallo


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30974-7
       
  • Drawing conclusions from the VIVA trial
    • Authors: Karsten Juhl Jørgensen; Minna Johansson
      First page: 1894
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Karsten Juhl Jørgensen, Minna Johansson


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30786-4
       
  • Drawing conclusions from the VIVA trial – Authors' reply
    • Authors: Jes S Lindholt; Rikke Søgaard
      Pages: 1894 - 1895
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Jes S Lindholt, Rikke Søgaard


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30757-8
       
  • Teriparatide vs risedronate for osteoporosis
    • Authors: Yair Liel
      First page: 1895
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Yair Liel


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30754-2
       
  • Teriparatide vs risedronate for osteoporosis – Authors' reply
    • Authors: David L Kendler; Piet Geusens; Cristiano A F Zerbini; Salvatore Minisola; Fernando Marin
      First page: 1896
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): David L Kendler, Piet Geusens, Cristiano A F Zerbini, Salvatore Minisola, Fernando Marin


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30756-6
       
  • Access to pathology and laboratory medicine services: a crucial gap
    • Authors: Michael L Wilson; Kenneth A Fleming; Modupe A Kuti; Lai Meng Looi; Nestor Lago; Kun Ru
      Pages: 1927 - 1938
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Michael L Wilson, Kenneth A Fleming, Modupe A Kuti, Lai Meng Looi, Nestor Lago, Kun Ru
      As global efforts accelerate to implement the Sustainable Development Goals and, in particular, universal health coverage, access to high-quality and timely pathology and laboratory medicine (PALM) services will be needed to support health-care systems that are tasked with achieving these goals. This access will be most challenging to achieve in low-income and middle-income countries (LMICs), which have a disproportionately large share of the global burden of disease but a disproportionately low share of global health-care resources, particularly PALM services. In this first in a Series of three papers on PALM in LMICs, we describe the crucial and central roles of PALM services in the accurate diagnosis and detection of disease, informing prognosis and guiding treatment, contributing to disease screening, public health surveillance and disease registries, and supporting medical-legal systems. We also describe how, even though data are sparse, these services are of both insufficient scope and inadequate quality to play their key role in health-care systems in LMICs. Lastly, we identify four key barriers to the provision of optimal PALM services in resource-limited settings: insufficient human resources or workforce capacity, inadequate education and training, inadequate infrastructure, and insufficient quality, standards, and accreditation.

      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30458-6
       
  • Improving pathology and laboratory medicine in low-income and
           middle-income countries: roadmap to solutions
    • Authors: Shahin Sayed; William Cherniak; Mark Lawler; Soo Yong Tan; Wafaa El Sadr; Nicholas Wolf; Shannon Silkensen; Nathan Brand; Lai Meng Looi; Sanjay A Pai; Michael L Wilson; Danny Milner; John Flanigan; Kenneth A Fleming
      Pages: 1939 - 1952
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Shahin Sayed, William Cherniak, Mark Lawler, Soo Yong Tan, Wafaa El Sadr, Nicholas Wolf, Shannon Silkensen, Nathan Brand, Lai Meng Looi, Sanjay A Pai, Michael L Wilson, Danny Milner, John Flanigan, Kenneth A Fleming
      Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a functioning health-care system at policy and governmental level, with the resultant inadequate investment, has meant that efforts to enhance PALM in low-income and middle-income countries have been local, fragmented, and mostly unsustainable. Responding to the four major barriers in PALM service delivery that were identified in the first paper of this Series (workforce, infrastructure, education and training, and quality assurance), this second paper identifies potential solutions that can be applied in low-income and middle-income countries (LMICs). Increasing and retaining a quality PALM workforce requires access to mentorship and continuing professional development, task sharing, and the development of short-term visitor programmes. Opportunities to enhance the training of pathologists and allied PALM personnel by increasing and improving education provision must be explored and implemented. PALM infrastructure must be strengthened by addressing supply chain barriers, and ensuring laboratory information systems are in place. New technologies, including telepathology and point-of-care testing, can have a substantial role in PALM service delivery, if used appropriately. We emphasise the crucial importance of maintaining PALM quality and posit that all laboratories in LMICs should participate in quality assurance and accreditation programmes. A potential role for public-private partnerships in filling PALM services gaps should also be investigated. Finally, to deliver these solutions and ensure equitable access to essential services in LMICs, we propose a PALM package focused on these countries, integrated within a nationally tiered laboratory system, as part of an overarching national laboratory strategic plan.

      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30459-8
       
  • Delivering modern, high-quality, affordable pathology and laboratory
           medicine to low-income and middle-income countries: a call to action
    • Authors: Susan Horton; Richard Sullivan; John Flanigan; Kenneth A Fleming; Modupe A Kuti; Lai Meng Looi; Sanjay A Pai; Mark Lawler
      Pages: 1953 - 1964
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Susan Horton, Richard Sullivan, John Flanigan, Kenneth A Fleming, Modupe A Kuti, Lai Meng Looi, Sanjay A Pai, Mark Lawler
      Modern, affordable pathology and laboratory medicine (PALM) systems are essential to achieve the 2030 Sustainable Development Goals for health in low-income and middle-income countries (LMICs). In this last in a Series of three papers about PALM in LMICs, we discuss the policy environment and emphasise three crucial high-level actions that are needed to deliver universal health coverage. First, nations need national strategic laboratory plans; second, these plans require adequate financing for implementation; and last, pathologists themselves need to take on leadership roles to advocate for the centrality of PALM to achieve the Sustainable Development Goals for health. The national strategic laboratory plan should deliver a tiered, networked laboratory system as a central element. Appropriate financing should be provided, at a level of at least 4% of health expenditure. Financing of new technologies such as molecular diagnostics is challenging for LMICs, even though many of these tests are cost-effective. Point-of-care testing can substantially reduce test-reporting time, but this benefit must be balanced with higher costs. Our research analysis highlights a considerable deficiency in advocacy for PALM; pathologists have been invisible in national and international health discourse and leadership. Embedding PALM in LMICs can only be achieved if pathologists advocate for these services, and undertake leadership roles, both nationally and internationally. We articulate eight key recommendations to address the current barriers identified in this Series and issue a call to action for all stakeholders to come together in a global alliance to ensure the effective provision of PALM services in resource-limited settings.

      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30460-4
       
  • Who is responsible for the vaccination of migrants in Europe'
    • Authors: Sally Hargreaves; Laura B Nellums; Mary Ramsay; Vanessa Saliba; Azeem Majeed; Sandra Mounier-Jack; Jon S Friedland
      Pages: 1752 - 1754
      Abstract: Publication date: 5–11 May 2018
      Source:The Lancet, Volume 391, Issue 10132
      Author(s): Sally Hargreaves, Laura B Nellums, Mary Ramsay, Vanessa Saliba, Azeem Majeed, Sandra Mounier-Jack, Jon S Friedland


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30846-8
       
  • Haemostatic treatment for intracerebral haemorrhage
    • Authors: Joseph P Broderick
      Abstract: Publication date: Available online 16 May 2018
      Source:The Lancet
      Author(s): Joseph P Broderick


      PubDate: 2018-05-17T06:40:16Z
      DOI: 10.1016/s0140-6736(18)31040-7
       
  • Talking about bereavement and grief
    • Authors: Farhat Yaqub
      Abstract: Publication date: Available online 14 May 2018
      Source:The Lancet
      Author(s): Farhat Yaqub


      PubDate: 2018-05-17T06:40:16Z
      DOI: 10.1016/s0140-6736(18)31065-1
       
  • REPLACE: a roadmap to make the world trans fat free by 2023
    • Authors: Tedros Adhanom Ghebreyesus; Thomas R Frieden
      Abstract: Publication date: Available online 14 May 2018
      Source:The Lancet
      Author(s): Tedros Adhanom Ghebreyesus, Thomas R Frieden


      PubDate: 2018-05-17T06:40:16Z
      DOI: 10.1016/s0140-6736(18)31083-3
       
  • Turning climate change legislation into public health policy
    • Authors: Lancet
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): The Lancet


      PubDate: 2018-05-13T10:13:21Z
       
  • Cancer drugs in China: affordability and creativity
    • Authors: Lancet
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): The Lancet


      PubDate: 2018-05-13T10:13:21Z
       
  • Vitamin A distribution in danger
    • Authors: Lancet
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): The Lancet


      PubDate: 2018-05-13T10:13:21Z
       
  • Concern over reported number of measles cases in Yemen
    • Authors: Xun Yuan
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Xun Yuan


      PubDate: 2018-05-13T10:13:21Z
       
  • Not much to say really
    • Authors: Kelvin Corcoran
      Abstract: Publication date: 12–18 May 2018
      Source:The Lancet, Volume 391, Issue 10133
      Author(s): Kelvin Corcoran


      PubDate: 2018-05-13T10:13:21Z
       
  • Stents in saphenous vein grafts
    • Authors: Raban V Jeger; Sven Möbius-Winkler
      Abstract: Publication date: Available online 11 May 2018
      Source:The Lancet
      Author(s): Raban V Jeger, Sven Möbius-Winkler


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30937-1
       
  • Immunoscore for (colorectal) cancer precision medicine
    • Authors: Shuji Ogino; Marios Giannakis
      Abstract: Publication date: Available online 10 May 2018
      Source:The Lancet
      Author(s): Shuji Ogino, Marios Giannakis


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30953-x
       
  • International validation of the consensus Immunoscore for the
           classification of colon cancer: a prognostic and accuracy study
    • Authors: Franck Bernhard; Mlecnik Florence Marliot Gabriela Bindea Fang-Shu Carlo Bifulco
      Abstract: Publication date: Available online 10 May 2018
      Source:The Lancet
      Author(s): Franck Pagès, Bernhard Mlecnik, Florence Marliot, Gabriela Bindea, Fang-Shu Ou, Carlo Bifulco, Alessandro Lugli, Inti Zlobec, Tilman T Rau, Martin D Berger, Iris D Nagtegaal, Elisa Vink-Börger, Arndt Hartmann, Carol Geppert, Julie Kolwelter, Susanne Merkel, Robert Grützmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Léonard, Christophe Remue, Julia Y Wang, P Bavi, Michael H A Roehrl, Pamela S Ohashi, Linh T Nguyen, SeongJun Han, Heather L MacGregor, Sara Hafezi-Bakhtiari, Bradly G Wouters, Giuseppe V Masucci, Emilia K Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Mihaela Angelova, Angela Vasaturo, Pauline Maby, Sarah E Church, Helen K Angell, Lucie Lafontaine, Daniela Bruni, Carine El Sissy, Nacilla Haicheur, Amos Kirilovsky, Anne Berger, Christine Lagorce, Jeffrey P Meyers, Christopher Paustian, Zipei Feng, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn van de Water, Shannon van Lent-van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragos-Viorel Scripcariu, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Kyogo Itoh, Prabhu S Patel, Hemangini H Vora, Birva Shah, Jayendrakumar B Patel, Kruti N Rajvik, Shashank J Pandya, Shilin N Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M Marincola, Paolo A Ascierto, Daniel J Sargent, Bernard A Fox, Jérôme Galon
      Background The estimation of risk of recurrence for patients with colon carcinoma must be improved. A robust immune score quantification is needed to introduce immune parameters into cancer classification. The aim of the study was to assess the prognostic value of total tumour-infiltrating T-cell counts and cytotoxic tumour-infiltrating T-cells counts with the consensus Immunoscore assay in patients with stage I–III colon cancer. Methods An international consortium of 14 centres in 13 countries, led by the Society for Immunotherapy of Cancer, assessed the Immunoscore assay in patients with TNM stage I–III colon cancer. Patients were randomly assigned to a training set, an internal validation set, or an external validation set. Paraffin sections of the colon tumour and invasive margin from each patient were processed by immunohistochemistry, and the densities of CD3+ and cytotoxic CD8+ T cells in the tumour and in the invasive margin were quantified by digital pathology. An Immunoscore for each patient was derived from the mean of four density percentiles. The primary endpoint was to evaluate the prognostic value of the Immunoscore for time to recurrence, defined as time from surgery to disease recurrence. Stratified multivariable Cox models were used to assess the associations between Immunoscore and outcomes, adjusting for potential confounders. Harrell's C-statistics was used to assess model performance. Findings Tissue samples from 3539 patients were processed, and samples from 2681 patients were included in the analyses after quality controls (700 patients in the training set, 636 patients in the internal validation set, and 1345 patients in the external validation set). The Immunoscore assay showed a high level of reproducibility between observers and centres (r=0·97 for colon tumour; r=0·97 for invasive margin; p<0·0001). In the training set, patients with a high Immunoscore had the lowest risk of recurrence at 5 years (14 [8%] patients with a high Immunoscore vs 65 (19%) patients with an intermediate Immunoscore vs 51 (32%) patients with a low Immunoscore; hazard ratio [HR] for high vs low Immunoscore 0·20, 95% CI 0·10–0·38; p<0·0001). The findings were confirmed in the two validation sets (n=1981). In the stratified Cox multivariable analysis, the Immunoscore association with time to recurrence was independent of patient age, sex, T stage, N stage, microsatellite instability, and existing prognostic factors (p<0·0001). Of 1434 patients with stage II cancer, the difference in risk of recurrence at 5 years was significant (HR for high vs low Immunoscore 0·33, 95% CI 0·21–0·52; p<0·0001), including in Cox multivariable analysis (p<0·0001). Immunoscore had the highest relative contribution to the risk of all clinical parameters, including the American Joint Committee on Cancer and Union for International Cancer Control TNM classification system....
      PubDate: 2018-05-13T10:13:21Z
       
  • Sexual and reproductive health and rights for all: an urgent need to
           change the narrative
    • Authors: Isaac Adewole; Alejandro Gavira
      Abstract: Publication date: Available online 9 May 2018
      Source:The Lancet
      Author(s): Isaac Adewole, Alejandro Gavira


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30888-2
       
  • Accelerate progress—sexual and reproductive health and rights for all:
           report of the Guttmacher–Lancet Commission
    • Authors: Ann M Starrs; Alex C Ezeh; Gary Barker; Alaka Basu; Jane T Bertrand; Robert Blum; Awa M Coll-Seck; Anand Grover; Laura Laski; Monica Roa; Zeba A Sathar; Lale Say; Gamal I Serour; Susheela Singh; Karin Stenberg; Marleen Temmerman; Ann Biddlecom; Anna Popinchalk; Cynthia Summers; Lori S Ashford
      Abstract: Publication date: Available online 9 May 2018
      Source:The Lancet
      Author(s): Ann M Starrs, Alex C Ezeh, Gary Barker, Alaka Basu, Jane T Bertrand, Robert Blum, Awa M Coll-Seck, Anand Grover, Laura Laski, Monica Roa, Zeba A Sathar, Lale Say, Gamal I Serour, Susheela Singh, Karin Stenberg, Marleen Temmerman, Ann Biddlecom, Anna Popinchalk, Cynthia Summers, Lori S Ashford


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30293-9
       
  • Abortion narratives: moving from statistics to stories
    • Authors: Lisa Hallgarten
      Abstract: Publication date: Available online 9 May 2018
      Source:The Lancet
      Author(s): Lisa Hallgarten


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)31036-5
       
  • Addressing the unfinished agenda on sexual and reproductive health and
           rights in the SDG era
    • Authors: Elizabeth Zuccala; Richard Horton
      Abstract: Publication date: Available online 9 May 2018
      Source:The Lancet
      Author(s): Elizabeth Zuccala, Richard Horton


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30890-0
       
  • Nyovani Madise: shining a light on the social determinants of SRHR
    • Authors: Geoff Watts
      Abstract: Publication date: Available online 9 May 2018
      Source:The Lancet
      Author(s): Geoff Watts


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30935-8
       
  • Defining sexual and reproductive health and rights for all
    • Authors: Tedros Adhanom Ghebreyesus; Natalia Kanem
      Abstract: Publication date: Available online 9 May 2018
      Source:The Lancet
      Author(s): Tedros Adhanom Ghebreyesus, Natalia Kanem


      PubDate: 2018-05-13T10:13:21Z
      DOI: 10.1016/s0140-6736(18)30901-2
       
  • Campaigning for preconception health
    • Authors: Lancet
      Abstract: Publication date: 5–11 May 2018
      Source:The Lancet, Volume 391, Issue 10132
      Author(s): The Lancet


      PubDate: 2018-05-13T10:13:21Z
       
  • Progress in the USA for autistic spectrum disorder
    • Authors: Lancet
      Abstract: Publication date: 5–11 May 2018
      Source:The Lancet, Volume 391, Issue 10132
      Author(s): The Lancet


      PubDate: 2018-05-13T10:13:21Z
       
  • Austerity in Spain: time to loosen the grip
    • Authors: Lancet
      Abstract: Publication date: 5–11 May 2018
      Source:The Lancet, Volume 391, Issue 10132
      Author(s): The Lancet


      PubDate: 2018-05-13T10:13:21Z
       
  • New leadership for the WHO Regional Office for the Eastern Mediterranean:
           exceptional election in an exceptional time
    • Authors: Samer Jabbour; Sameen Siddiqi; Rita Giacaman; Hani Serag; Jawad Al-Lawati; Amirhossein Takian; Habiba Ben Romdhane; Elsheikh Badr; Laith J Abu-Raddad; Aida Seif El-Dawla; Salwa Najjab; Driss Moussaoui; Mustafa Khogali; Yousef Khader; Bothaina Attal; Iman Nuwayhid
      Abstract: Publication date: Available online 2 May 2018
      Source:The Lancet
      Author(s): Samer Jabbour, Sameen Siddiqi, Rita Giacaman, Hani Serag, Jawad Al-Lawati, Amirhossein Takian, Habiba Ben Romdhane, Elsheikh Badr, Laith J Abu-Raddad, Aida Seif El-Dawla, Salwa Najjab, Driss Moussaoui, Mustafa Khogali, Yousef Khader, Bothaina Attal, Iman Nuwayhid


      PubDate: 2018-05-03T06:57:09Z
      DOI: 10.1016/s0140-6736(18)31029-8
       
  • Department of Error
    • Abstract: Publication date: Available online 27 April 2018
      Source:The Lancet


      PubDate: 2018-05-02T06:55:50Z
       
  • What proportion of older adults in hospital are frail'
    • Authors: Samuel D Searle; Kenneth Rockwood
      Abstract: Publication date: Available online 26 April 2018
      Source:The Lancet
      Author(s): Samuel D Searle, Kenneth Rockwood


      PubDate: 2018-05-02T06:55:50Z
      DOI: 10.1016/s0140-6736(18)30907-3
       
  • Can improving access to care help to eliminate malaria'
    • Authors: Azra C Ghani
      Abstract: Publication date: Available online 24 April 2018
      Source:The Lancet
      Author(s): Azra C Ghani


      PubDate: 2018-04-25T03:07:02Z
      DOI: 10.1016/s0140-6736(18)30910-3
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-